- $526.66m
- $241.38m
- $326.13m
- 73
- 29
- 30
- 40
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 327 | 106 | 187 | 261 | 326 |
Cost of Revenue | |||||
Gross Profit | 198 | 43.7 | 117 | 170 | 225 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 398 | 304 | 305 | 308 | 367 |
Operating Profit | -71.7 | -198 | -118 | -46.7 | -41.1 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -69 | -225 | -138 | -55.3 | -24.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -68.8 | -225 | -139 | -55.4 | -26.5 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -68.8 | -225 | -139 | -55.4 | -26.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -68.8 | -225 | -139 | -55.4 | -26.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.818 | -2.43 | -1.13 | -0.563 | -0.158 |